Latest News

August 11, 2014
Osteoporosis drugs known as bisphosphonates may not protect women from breast cancer as had been thought, according to a new study led by researchers at UCSF.
August 07, 2014
New research partly led by UCSF-affiliated scientists suggests that one in 10 cancer patients would be more accurately diagnosed if their tumors were defined by cellular and molecular criteria rather than by the tissues in which they originated.
April 07, 2014
In an innovative clinical trial led by UCSF, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed, high-risk breast cancer.
April 01, 2014
Doctors should focus on life expectancy when deciding whether to order mammograms for their oldest female patients, since the harms of screening likely outweigh the benefits unless women are expected to live at least another decade, according to a review of the scientific literature by experts at UCSF and Harvard medical schools.
March 27, 2014
The stiffening of breast tissue in breast-cancer development points to a new way to distinguish a type of breast cancer with a poor prognosis from a related, but often less deadly type, UCSF researchers have found in a new study.
March 17, 2014
One of the world’s preeminent cancer scientists, Alan Ashworth, PhD, FRS, has been appointed the new director of the UCSF Helen Diller Family Comprehensive Cancer Center.
March 11, 2014
Laura van ‘t Veer, PhD, was honored this week as one of the top female scientific innovators in Europe, winning one of the 2014 European Union Prizes for Women Innovators.
February 03, 2014
New guidelines recommending screening mammography every two years for women ages 50 to 74 would save the United States $4.3 billion a year in health care costs, according to a UCSF-led study.
January 09, 2014
Scientists have discovered a type of RNA that could have enormous potential for better diagnosing and treating many types of cancer, Alzheimer's, multiple sclerosis and other diseases.
October 03, 2013
Often deadly “triple-negative” breast cancers might be effectively treated in many cases with a drug that targets a previously unknown vulnerability in the tumors, UCSF reports.

Pages